{"transactions":[{"id":2437088,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":131423,"kind":"person","name":"McKenzie Kathryn B","position":1,"cik":"0001720001","reported_name":"McKenzie Kathryn B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Sustainability/Risk Ofcr"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-12T23:50:42.000Z","date":"2022-01-11","kind":"exercise","acquired":false,"shares":2100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On October 17, 2017, Ms. McKenzie was granted 25,000 stock options. These options vested ratably over the first three anniversary dates of the grant date."}],"balance_after":17900,"derivative":{"exercise_price":9.07,"expiration_date":"2022-10-18","underlying":"Common Stock","underlying_shares":2100},"source":{"system":"sec-edgar","filing":"0001077183-22-000002","document":"wf-form4_164203142741919.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718322000002/wf-form4_164203142741919.xml","form_type":"4"}},{"id":2437087,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":131423,"kind":"person","name":"McKenzie Kathryn B","position":1,"cik":"0001720001","reported_name":"McKenzie Kathryn B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Sustainability/Risk Ofcr"}}],"security":"Common Stock","published_at":"2022-01-12T23:50:42.000Z","date":"2022-01-11","kind":"exercise","acquired":true,"shares":2100,"price":9.07,"value":19047.0,"ownership":{"direct":true},"balance_after":49361,"source":{"system":"sec-edgar","filing":"0001077183-22-000002","document":"wf-form4_164203142741919.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718322000002/wf-form4_164203142741919.xml","form_type":"4"}},{"id":2456458,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":131423,"kind":"person","name":"McKenzie Kathryn B","position":1,"cik":"0001720001","reported_name":"McKenzie Kathryn B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-12-30T23:04:23.000Z","date":"2021-12-30","kind":"grant","acquired":true,"shares":30572,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 30, 2021, Ms. McKenzie was granted 30,572 restricted stock awards. These awards vest ratably over three years with the first tranche vesting on December 31, 2022."}],"balance_after":47261,"source":{"system":"sec-edgar","filing":"0001077183-21-000276","document":"wf-form4_164090544806977.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718321000276/wf-form4_164090544806977.xml","form_type":"4"}},{"id":2460060,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":131423,"kind":"person","name":"McKenzie Kathryn B","position":1,"cik":"0001720001","reported_name":"McKenzie Kathryn B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-23T22:25:27.000Z","date":"2021-12-22","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On October 17, 2017, Ms. McKenzie was granted 25,000 stock options. These options vested ratably over the first three anniversary dates of the grant date"}],"balance_after":20000,"derivative":{"exercise_price":9.07,"expiration_date":"2022-10-18","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001077183-21-000260","document":"wf-form4_164029831264611.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718321000260/wf-form4_164029831264611.xml","form_type":"4"}},{"id":2460059,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":131423,"kind":"person","name":"McKenzie Kathryn B","position":1,"cik":"0001720001","reported_name":"McKenzie Kathryn B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-12-23T22:25:27.000Z","date":"2021-12-22","kind":"exercise","acquired":true,"shares":5000,"price":9.07,"value":45350.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":16689,"source":{"system":"sec-edgar","filing":"0001077183-21-000260","document":"wf-form4_164029831264611.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718321000260/wf-form4_164029831264611.xml","form_type":"4"}},{"id":2460058,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":131423,"kind":"person","name":"McKenzie Kathryn B","position":1,"cik":"0001720001","reported_name":"McKenzie Kathryn B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-12-23T22:25:27.000Z","date":"2021-12-21","kind":"sale","acquired":false,"shares":1846,"price":35,"value":64610.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":11689,"source":{"system":"sec-edgar","filing":"0001077183-21-000260","document":"wf-form4_164029831264611.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718321000260/wf-form4_164029831264611.xml","form_type":"4"}},{"id":2815575,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":131423,"kind":"person","name":"McKenzie Kathryn B","position":1,"cik":"0001720001","reported_name":"McKenzie Kathryn B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-04T01:19:40.000Z","date":"2021-03-02","kind":"grant","acquired":true,"shares":35171,"price":53.17,"value":1870042.07,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"On March 2, 2021, Ms. McKenzie was granted 35,171 stock options. These options vest ratably over the first four anniversary dates of the grant date."}],"balance_after":35171,"derivative":{"exercise_price":53.17,"expiration_date":"2028-03-02","underlying":"Common Stock","underlying_shares":35171},"source":{"system":"sec-edgar","filing":"0001077183-21-000087","document":"wf-form4_161482075291006.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718321000087/wf-form4_161482075291006.xml","form_type":"4"}},{"id":2815574,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":131423,"kind":"person","name":"McKenzie Kathryn B","position":1,"cik":"0001720001","reported_name":"McKenzie Kathryn B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-03-04T01:19:40.000Z","date":"2021-03-02","kind":"grant","acquired":true,"shares":6207,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13535,"source":{"system":"sec-edgar","filing":"0001077183-21-000087","document":"wf-form4_161482075291006.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718321000087/wf-form4_161482075291006.xml","form_type":"4"}},{"id":2815573,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":131423,"kind":"person","name":"McKenzie Kathryn B","position":1,"cik":"0001720001","reported_name":"McKenzie Kathryn B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-03-04T01:19:40.000Z","date":"2021-03-02","kind":"tax_withholding","acquired":false,"shares":432,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 2, 2021 vesting of restricted stock."}],"balance_after":7328,"source":{"system":"sec-edgar","filing":"0001077183-21-000087","document":"wf-form4_161482075291006.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718321000087/wf-form4_161482075291006.xml","form_type":"4"}},{"id":2815572,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":131423,"kind":"person","name":"McKenzie Kathryn B","position":1,"cik":"0001720001","reported_name":"McKenzie Kathryn B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-03-04T01:19:40.000Z","date":"2021-03-01","kind":"tax_withholding","acquired":false,"shares":169,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 1, 2021 vesting of restricted stock."}],"balance_after":7760,"source":{"system":"sec-edgar","filing":"0001077183-21-000087","document":"wf-form4_161482075291006.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718321000087/wf-form4_161482075291006.xml","form_type":"4"}},{"id":3234154,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":131423,"kind":"person","name":"McKenzie Kathryn B","position":1,"cik":"0001720001","reported_name":"McKenzie Kathryn B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-03-04T01:00:37.000Z","date":"2020-03-02","kind":"grant","acquired":true,"shares":37514,"price":28.33,"value":1062771.62,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On March 2, 2020, Ms. McKenzie was granted 37,514 stock options. These options vest ratably over the first four anniversary dates of the grant date."}],"balance_after":37514,"derivative":{"exercise_price":28.33,"exercise_date":"2021-03-02","expiration_date":"2027-03-02","underlying":"Common Stock","underlying_shares":37514},"source":{"system":"sec-edgar","filing":"0001077183-20-000030","document":"wf-form4_158328361900393.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718320000030/wf-form4_158328361900393.xml","form_type":"4"}},{"id":3234153,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":131423,"kind":"person","name":"McKenzie Kathryn B","position":1,"cik":"0001720001","reported_name":"McKenzie Kathryn B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-03-04T01:00:37.000Z","date":"2020-03-02","kind":"grant","acquired":true,"shares":5824,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7929,"source":{"system":"sec-edgar","filing":"0001077183-20-000030","document":"wf-form4_158328361900393.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718320000030/wf-form4_158328361900393.xml","form_type":"4"}},{"id":3234152,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":131423,"kind":"person","name":"McKenzie Kathryn B","position":1,"cik":"0001720001","reported_name":"McKenzie Kathryn B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-03-04T01:00:37.000Z","date":"2020-03-01","kind":"tax_withholding","acquired":false,"shares":168,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by NeoGenomics Inc. to satisfy the tax obligations in connection with the March 1, 2020 vesting of restricted stock."}],"balance_after":2105,"source":{"system":"sec-edgar","filing":"0001077183-20-000030","document":"wf-form4_158328361900393.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718320000030/wf-form4_158328361900393.xml","form_type":"4"}},{"id":3344020,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":131423,"kind":"person","name":"McKenzie Kathryn B","position":1,"cik":"0001720001","reported_name":"McKenzie Kathryn B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-13T00:28:27.000Z","date":"2019-12-10","kind":"exercise","acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 26, 2018, Ms. McKenzie was granted an option to purchase 48,000 shares of NeoGenomics, Inc. common stock.  The options vest ratably over the first three anniversary dates of the grant date."}],"balance_after":40000,"derivative":{"exercise_price":8.03,"exercise_date":"2019-02-26","expiration_date":"2023-02-26","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001077183-19-000230","document":"wf-form4_157619689019440.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718319000230/wf-form4_157619689019440.xml","form_type":"4"}},{"id":3344019,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":131423,"kind":"person","name":"McKenzie Kathryn B","position":1,"cik":"0001720001","reported_name":"McKenzie Kathryn B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2019-12-13T00:28:27.000Z","date":"2019-12-10","kind":"sale","acquired":false,"shares":8000,"price":26.37,"value":210960.0,"ownership":{"direct":true},"balance_after":2273,"source":{"system":"sec-edgar","filing":"0001077183-19-000230","document":"wf-form4_157619689019440.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718319000230/wf-form4_157619689019440.xml","form_type":"4"}},{"id":3344018,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":131423,"kind":"person","name":"McKenzie Kathryn B","position":1,"cik":"0001720001","reported_name":"McKenzie Kathryn B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2019-12-13T00:28:27.000Z","date":"2019-12-10","kind":"exercise","acquired":true,"shares":8000,"price":8.03,"value":64240.0,"ownership":{"direct":true},"balance_after":10273,"source":{"system":"sec-edgar","filing":"0001077183-19-000230","document":"wf-form4_157619689019440.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718319000230/wf-form4_157619689019440.xml","form_type":"4"}},{"id":3614793,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":131423,"kind":"person","name":"McKenzie Kathryn B","position":1,"cik":"0001720001","reported_name":"McKenzie Kathryn B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-03-05T21:59:09.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":13894,"price":19.6,"value":272322.4,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On March 1, 2019, Ms. McKenzie was granted an option to purchase 13,894 shares of NeoGenomics, Inc. common stock.  The options vest ratably over the first four anniversary dates of the grant date."}],"balance_after":13894,"derivative":{"exercise_price":19.6,"exercise_date":"2020-03-01","expiration_date":"2024-03-01","underlying":"Common Stock","underlying_shares":13894},"source":{"system":"sec-edgar","filing":"0001077183-19-000029","document":"wf-form4_155182313355816.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718319000029/wf-form4_155182313355816.xml","form_type":"4"}},{"id":3614792,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":131423,"kind":"person","name":"McKenzie Kathryn B","position":1,"cik":"0001720001","reported_name":"McKenzie Kathryn B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2019-03-05T21:59:09.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":2273,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2273,"source":{"system":"sec-edgar","filing":"0001077183-19-000029","document":"wf-form4_155182313355816.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718319000029/wf-form4_155182313355816.xml","form_type":"4"}},{"id":4028210,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":131423,"kind":"person","name":"McKenzie Kathryn B","position":1,"cik":"0001720001","reported_name":"McKenzie Kathryn B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-28T23:59:29.000Z","date":"2018-02-26","kind":"grant","acquired":true,"shares":48000,"price":8.03,"value":385440.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 26, 2018, Ms. McKenzie was granted an option to purchase 48,000 shares of NeoGenomics, Inc. common stock.  The options vest ratably over the first three anniversary dates of the grant date."}],"balance_after":48000,"derivative":{"exercise_price":8.03,"exercise_date":"2019-02-26","expiration_date":"2023-02-26","underlying":"Common Stock","underlying_shares":48000},"source":{"system":"sec-edgar","filing":"0001209191-18-014684","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000120919118014684/doc4.xml","form_type":"4"}},{"id":4182599,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":131423,"kind":"person","name":"McKenzie Kathryn B","position":1,"cik":"0001720001","reported_name":"McKenzie Kathryn B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-10-20T20:03:35.000Z","date":"2017-10-18","kind":"grant","acquired":true,"shares":25000,"price":9.07,"value":226750.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On October 18, 2017, Ms. McKenzie was granted an option to purchase 25,000 shares of NeoGenomics, Inc. common stock.  The options vest ratably over the first three anniversary dates of the grant date."}],"balance_after":25000,"derivative":{"exercise_price":9.07,"exercise_date":"2018-10-18","expiration_date":"2022-10-18","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-17-057606","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000120919117057606/doc4.xml","form_type":"4"}}]}